New York, NY -- (SBWIRE) -- 01/22/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Ballard Power Systems Inc. (USA) (NASDAQ:BLDP), WidePoint Corporation (NYSEMKT:WYY), IsoRay, Inc (NYSEMKT:ISR), Idenix Pharmaceuticals Inc (NASDAQ:IDIX)
Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) showed a volume of 1.92 million shares by the end of last trade whereas the average volume of the stock remained 4.01million shares. The stock opened the session at $2.41 but then moved to $2.30. At that price, the stock showed a negative performance of -1.29%. Ballard Power Systems Inc. (Ballard) is engaged in design, development, manufacture, sale and service of fuel cell products for a variety of applications, focusing on motive power (material handling and buses) and stationary power (back-up power and distributed generation).
Will BLDP Get Buyers Even After The Recent Rally? Find Out Here
WidePoint Corporation (NYSEMKT:WYY) opened the session at $-6.84 and closed the session at $1.77. The stock showed a negative performance of -6.84% in previous trading session. Traded with volume of 1.90 million shares in the prior session and the average volume of the stock remained 1.61 million shares. WidePoint Corporation (WidePoint) is a provider of customized technology-based products and solutions to both the government sector and commercial markets.
Has WYY Found The Bottom And Ready To Gain Momentum? Find Out Here
IsoRay, Inc (NYSEMKT:ISR) opened the session at $0.90 and closed the session at $0.935. The stock showed a positive performance of 8.09% in previous trading session. Traded with volume of 1.89 million shares in the prior session and the average volume of the stock remained 1.35 million shares. The beta of the stock remained 0.27. IsoRay, Inc. (IsoRay) develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. IsoRay International LLC (International) is a wholly owned subsidiary of the Company.
Why Should Investors Buy ISR After The Recent Gain? Just Go Here and Find Out
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) traded with volume of 1.88 million shares in the prior session and the average volume of the stock remained 1.28 million shares. The beta of the stock remained 0.44. Idenix Pharmaceuticals, Inc. (Idenix) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France.
Is IDIX a Solid Investment at These Levels? Read This Report For Details
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)